Thor Medical Share Price

NANOV

NO0010597883

Biotechnology & Medical Research

Market Closed - Oslo Bors 15:45:00 19/10/2026 BST			5-day change	1st Jan Change
4.425 ^NOK	-0.34%		-0.11%	-15.71%

10-07	Thor Medical ASA Opens AlphaOne Production Facility At Herøya Industrial Park	CI
09-20	Thor Medical ASA(OB:TRMED) added to S&P Global BMI Index	CI

Last Transcript: Thor Medical

Thor Medical ASA, H1 2026 Earnings Call, Aug 28, 2026

08-28

More transcripts

News in other languages: Thor Medical

08-20	Avis d'analystes du jour : ça bouge sur Michelin, Sartorius, Pandora et Merck KGaA
02/06/22	Actualización de las fuertes variaciones del día: EcoOnline despierta su sector, Klöckner ajuste después de dividendo
02/06/22	Point sur les fortes variations du jour : Saint-Gobain réveille son secteur, Esker trop prudent
19/02/21	Avis d'analystes du jour : L'Oréal, Air France KLM, Nestlé, Orange, Campari, Moncler, BioMérieux, Stratec...
19/02/21	Des PMI et des sorcières pour terminer la semaine

More news

Managers and Directors: Thor Medical

Manager	Title	Age	Since
Jasper Kurth CEO	Chief Executive Officer	41	31/07/2024
Brede Høyland Ellingsæter DFI	Director of Finance/CFO	37	30/06/2023
Sindre Hassfjell CTO	Chief Tech/Sci/R&D Officer	-	31/05/2023

Director	Title	Age	Since
Mimi Kristine Berdal BRD	Director/Board Member	67	27/06/2023
John Andersen CHM	Chairman	59	-
Jens Gisle Schnelle BRD	Director/Board Member	-	23/04/2025

More insiders

Thor Medical ASA, formerly Nordic Nanovector ASA, is a Norway-based biopharmaceutical company. The Company is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium. The Company is utilizing alpha-emitters in radiotherapy and cancer treatments using Pb-212, which can be produced from naturally occurring isotope Thorium-232 and Lead-212. The Company has developed a proprietary technology for the manufacturing of radionuclides, primarily alpha-particle emitters from natural resources. The high energy deposition and the short range of alpha particles make it possible to eradicate cancer cells while minimizing damage to nearby healthy cells

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
19/10/26	NOK 4.425	-0.34%	3,268,682
16/10/26	NOK 4.440	+3.02%	2,019,987
15/10/26	NOK 4.310	-2.49%	2,050,584
14/10/26	NOK 4.420	+1.38%	997,841
13/10/26	NOK 4.360	-1.58%	1,469,560

Real-time Oslo Bors

More quotes

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

4.440NOK

Average target price

4.200NOK

Spread / Average Target

-5.41%

Consensus

EPS Estimates

Evolution of Analysts' Estimates - EPS - Thor Medical

Revisions to estimates

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Thor Medical

Company calendar

Market Cap	1.88B 199M 178M 165M 150M 281M 18.89B 285M 1.97B 776M 9.87B 748M 732M 31.56B	P/E 2026 *	-24.7x	P/E 2027 *	-44.4x
Enterprise Value	2.07B 220M 196M 182M 165M 310M 20.88B 315M 2.18B 858M 10.91B 826M 809M 34.88B	EV / Sales 2026 *	104x	EV / Sales 2027 *	14.3x
Free-Float	75.21%	Yield 2026 *	-	Yield 2027 *	-

Markets		Quality
Oslo Bors	NANOV	Real-time
CBOE	NANOo	Real-time
London S.E.	0R6Y	End-of-day quote
Tradegate	8NN	Real-time
Nasdaq Stockholm	NANOVO	Delayed
Deutsche Boerse AG	8NN	Delayed
London S.E.	0R6Y	Delayed
CBOE	0R6Y	Real-time
Börse Stuttgart	8NN	Delayed
Boerse Muenchen	8NN	Real-time
Berne S.E.	8NN	End-of-day quote

10-07	Thor Medical ASA Opens AlphaOne Production Facility At Herøya Industrial Park	CI
09-20	Thor Medical ASA(OB:TRMED) added to S&P Global BMI Index	CI
08-28	Thor Medical ASA Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-28	Thor Medical ASA, H1 2026 Earnings Call, Aug 28, 2026
08-25	Thor Medical's COO, CFO Transitions to Dedicated COO Role	MT
08-25	Thor Medical Asa CFO Brede Ellingsæter to Transition into Full-Time COO Role	CI
08-19	Thor Medical Asa Alphaone Facility Officially Opened by Norwegian Prime Minister Jonas Gahr Støre	CI
08-05	Thor Medical Completes Maiden Thorium-228 Isotope Delivery from AlphaOne Plant	MT
08-05	Thor Medical Asa Completes First Customer Delivery from Alphaone Production Facility	CI
07-31	Thor Medical ASA Starts Commercial Production At AlphaOne Facility	CI
06-16	Thor Medical ASA Announces Retirement of Alf Bjørseth from EVP Business Development, Effective June 30, 2026	CI
05-29	Thor Medical ASA Enters Collaboration and Supply Agreement With Minerva Imaging	CI
05-29	Thor Medical Lands Deal to Supply Cancer Treatment Isotope	MT

10-07	Thor Medical : Norwegian Prime Minister Jonas Gahr Støre to Officially Open Thor Medical's AlphaOne Facility on October 19	PU
09-22	Thor Medical ASA: Cancellation of Subsequent Offering	PU
09-11	Thor Medical ASA: Completed Redelivery of Shares	PU
09-10	Thor Medical ASA: Primary Insider Notification in Relation to Redelivery of Shares	PU
09-10	Thor Medical ASA: Disclosure of Large Shareholding	PU

1 day	-0.34%
1 week	-0.11%
Current month	-1.01%
1 month	-5.14%
3 months	+3.87%
6 months	-12.38%
Current year	-15.71%

Thor Medical Share Price

Stocks

NANOV

NO0010597883

Biotechnology & Medical Research

Valuation: Thor Medical

Chart: Thor Medical

Latest news: Thor Medical

Last Transcript: Thor Medical

Press Releases: Thor Medical

News in other languages: Thor Medical

Quotes and Performance

Price Extremes

Managers and Directors: Thor Medical

Latest insider transactions

Bio Therapeutic Drugs

Financials

Company Profile

Quotes

Analysts' Consensus

Annual profits - Rate of surprise

1 week	4.28	4.52
1 month	4.28	4.9
Current year	3.88	7.12
1 year	3.31	7.12
3 years	0.85	7.12
5 years	0.85	7.12
10 years	0.85	7.12

Date	Insider	Type	Main position	Quantity	% Market Cap.
26/06/25	Scatec Innovation AS	Others	Company	31,577,399	10.0434%
18/06/25	Scatec Innovation AS	Buy	Company	3,000,000	0.9542%
02/05/25	Mimi Kristine Berdal	Exercice	Director	54,880	0.0175%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
THOR MEDICAL	-0.34%	-0.11%	+24.30%	+256.85%	199M
WUXI APPTEC CO., LTD.	+1.52%	-7.16%	+51.66%	+67.41%	65B
LONZA GROUP AG	+1.52%	+6.83%	+10.89%	+79.30%	51.2B
ARGENX SE	+0.30%	-0.46%	-0.03%	+61.89%	51.19B
IQVIA HOLDINGS INC.	-0.84%	+0.92%	+24.79%	+41.69%	43.93B
BEONE MEDICINES AG	+0.65%	+6.02%	+16.61%	+134.13%	41.96B
REVOLUTION MEDICINES, INC.	+2.36%	-6.21%	+236.82%	+527.29%	38.14B
CELLTRION, INC.	+2.16%	+10.36%	+18.92%	+59.70%	33.24B
WUXI BIOLOGICS (CAYMAN) INC.	-0.90%	-10.49%	+37.09%	+1.80%	25.2B
GENMAB A/S	+1.60%	+2.21%	+27.96%	+28.00%	22.5B
Average	+0.77%	+0.09%	+44.90%	+125.81%	37.26B
Weighted average by Cap.	+0.91%	+0.04%	+45.44%	+112.44%

	2026 *	2027 *
Net sales	20M 2.12M 1.89M 1.75M 1.59M 2.99M 201M 3.04M 21.04M 8.27M 105M 7.97M 7.8M 337M	145M 15.4M 13.73M 12.72M 11.56M 21.7M 1.46B 22.06M 153M 59.98M 763M 57.79M 56.58M 2.44B
Net income	-70M -7.44M -6.63M -6.14M -5.58M -10.48M -705M -10.65M -73.64M -28.96M -368M -27.9M -27.31M -1.18B	-44M -4.67M -4.17M -3.86M -3.51M -6.58M -443M -6.69M -46.29M -18.2M -232M -17.54M -17.17M -740M
Net Debt	197M 20.93M 18.65M 17.28M 15.71M 29.48M 1.98B 29.97M 207M 81.5M 1.04B 78.51M 76.87M 3.31B	201M 21.35M 19.03M 17.63M 16.03M 30.08M 2.02B 30.57M 211M 83.15M 1.06B 80.1M 78.43M 3.38B